LncRNA ITGB2-AS1 promotes cisplatin resistance of non-small cell lung cancer by inhibiting ferroptosis via activating the FOSL2/NAMPT axis

LncRNA ITGB2-AS1 promotes cisplatin resistance of non-small cell lung cancer by inhibiting ferroptosis via activating the FOSL2/NAMPT axis

Cisplatin resistance is a major therapeutic challenge in non-small cell lung cancer (NSCLC). Herein, the regulatory role of long non-coding RNA (lncRNA) ITGB2-AS1 in regulating NSCLC cisplatin resistance was investigated. NSCLC cisplatin resistance cells were constructed using A549 and H1975 cells....

Full description

Bibliographic Details
Main Authors: Huiyong Chen, Linhui Wang, Jingting Liu, Zihao Wan, Lin Zhou, Hongliang Liao, Renping Wan
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Cancer Biology & Therapy
Subjects:
non-small cell lung cancer
cisplatin resistance
ferroptosis
lncrna itgb2-as1
nampt
Online Access:http://dx.doi.org/10.1080/15384047.2023.2223377

Internet

http://dx.doi.org/10.1080/15384047.2023.2223377

Similar Items